Breathe BioMedical is excited to announce that we are continuing to build our Boston presence by participating in the TiE ScaleUp accelerator program. The program is led by TiE Boston, a nonprofit dedicated to fostering entrepreneurship and one of the largest chapters of the TiE Global network. The five-month program supports scaling start-up companies through valuable mentorship, connections, and resources. As the TiE Boston chapter celebrates its 25th anniversary, Breathe BioMedical is thrilled to be a part of Cohort 8 alongside fourteen other incredible startups to benefit from peer-to-peer learning as well as advice from proven leaders and entrepreneurs in the medical device space.
At Breathe BioMedical we are always looking to expand our reach and teach others about our ground-breaking Breath Metabolomics technology. Through TiE ScaleUp, we will continue to develop alliances with advisors, investors, and other partners in Boston and beyond as we work to accomplish our goals and mission.
ScaleUp Program Manager, Dean Walsh, shared the following: “It’s great to have the opportunity to work with COO Bill Dawes to elevate the life-saving work Breath BioMedical is doing. We’re proud to have BBM in the program, and we look forward to helping the team develop the partnerships they need to optimize their go-to-market strategy and prepare for commercialization.”
“The exposure, support, and mentorship of the TiE ScaleUp program is already proving to be highly valuable,” said Bill Dawes, COO. “We’re at a critical stage for our business, and we’re looking forward to the opportunities this program will provide for Breathe BioMedical.
Breathe BioMedical welcomes the opportunity to grow our business network. If you are interested in partnering with Breathe BioMedical, email us at firstname.lastname@example.org.
About TiE Boston: A member-based organization founded in 1997 by a group of successful entrepreneurs, corporate executives, and senior professionals of Indian origin, in order to foster future innovators. Their unparalleled network of successful, serial entrepreneurs are deeply engaged and committed to giving back to the community by providing mentorship, tactical advice, and expertise to rising entrepreneurs.
About Breathe BioMedical: Breathe BioMedical is a Canadian medical device company developing and manufacturing ground-breaking technology for breath analytics including our FDA-listed breath collection device SohnoXB. Breath analytics involves the collection, processing and analysis of breath samples to identify biomarkers patterns associated with specific diseases. Breathe BioMedical has completed a proof-of-concept study demonstrating our technology’s ability to detect non-small cell lung cancer with accuracy of 86.1%. Breathe BioMedical has also partnered on two additional independent research studies to detect breast cancer and COVID-19 with plans to expand research in 2022. Breathe BioMedical’s research and development laboratory is in Moncton, New Brunswick and its US subsidiary is located in Boston, MA. One day, detecting disease will be as easy as breathing in and out.